September 5, 2014

Thomas Sellers
Tampa Bay Business Journal – Sept. 5
Sellers, executive vice president and center director of Moffitt Cancer Center, has been elected to the Association of American Cancer Institutes Board of Directors. His three-year term will begin Oct. 26.

FDA Approves Pembrolizumab for Advanced Melanoma
OncLive – Sept. 4
“Pembrolizumab is the first PD-1 drug to be approved by the FDA, and it is a clearly effective drug that will prolong survival for many patients with metastatic melanoma,” Jeffrey S. Weber, MD, PhD, the director of the Donald A. Adam Comprehensive Melanoma Research Center of Excellence at Moffitt Cancer Center, said in a statement. “This approval is a real advance, and a major milestone in the treatment of the disease.”

'Corks for Cancer'
Orlando Sentinel – Sept. 4
Lakeridge Winery & Vineyards will host “Corks for Cancer Festival” to benefit the Moffitt Cancer Center Sept. 13 and 14 at the winery, 19239 U.S. Highway 27 north of Clermont.

Surviving cancer seminar
The Laker/Lutz News – Sept. 3
Dr. Roberto Diaz from the H. Lee Moffitt Cancer Center & Research Institute will speak about surviving cancer Sept. 25 at 7 p.m., at Keystone Community Church, 21010 State Road 54 in Lutz.

Demystifying 3D Mammography, A Radiologist’s Perspective
Doctor’s Life Magazine – September 2014
By Jennifer Drukteinis, Moffitt Cancer Center

Extraordinary ordinaries - The ART of healing
My Fox Tampa Bay – Sept. 3
For Ray Paul, his garage is his temple. His art, is his zen. Ray’s been a working artist since 1991.  USF College of the Arts is showing his work in the halls of the Moffitt Cancer Center.

AACI Members Choose Gerson, Loeher, Sellers for Board
AACI Update – Sept. 2
Stanton L. Gerson, MD, Patrick J. Loehrer, Sr., MD, and Thomas A. Sellers, PhD, MPH, have been elected to the Association of American Cancer Institutes’ board of directors.

Walker school principal remembered as coach, friend
Highlands Today – Sept. 2
It wasn’t uncommon to see him out after school, being one of the kids. Even in the heat of a spring sun, William Farmer would often join the Walker Memorial Academy students for a pick-up, after-school game of softball. Farmer, who moved from Fort Myers to Highlands County in 1986, died at Moffitt Cancer Center in Tampa.

Which Affects Cancer Treatment Outcomes More: Age or Comorbidities?
ONS Connect – Sept. 2
Martine Extermann, MD, PhD, is a senior adult oncologist at Moffitt Cancer Center in Tampa, FL, who has spent her career researching the impact of age and comorbidities on cancer care.

Commentary: Time to hold private Medicare Advantage plans accountable
The Palm Beach Post – Sept. 2
In the past 12 months, Humana and United Healthcare — two of the largest Medicare Advantage programs — dropped thousands of physicians including many of the top physicians in the country — such as practitioners at Tampa’s nationally renowned H. Lee Moffitt Cancer Center and the entire Yale Medical School faculty.

AACI Members Elect New Leadership, Members to Board of Directors
The ASCO Post – Sept. 1
The Association also announced that Patrick J. Loehrer, Sr, MD, and Thomas A. Sellers, PhD, MPH, have been elected to AACI’s Board of Directors. Dr. Loehrer is Director of the Indiana University Melvin and Bren Simon Cancer Center, in Indianapolis. Dr. Sellers is Director and Executive Vice President of the Moffitt Cancer Center and Research Institute, in Tampa.

Emerging Approaches in Acute Myeloid Leukemia, A Conversation With Hugo F. Fernandez, MD
The ASCO Post – Sept. 1
With the emergence of molecular diagnostics and new therapeutics, the treatment of acute myeloid leukemia (AML) is entering a new era. Hugo F. Fernandez, MD, Associate Chief of Blood and Marrow Transplantation at Moffitt Cancer Center in Tampa, Florida, spoke with The ASCO Post about how he approaches these patients.

Rays: Reliever Steve Geltz surprised by promotion
Tampa Bay Times – Sept. 1
Led by 3B Evan Longoria, Rays players today will wear Strikeout Cancer T-shirts, featuring a backward K in team colors, to raise awareness and funds for the Moffitt Cancer Center. 

Boomer profile: Cliff P. Connery
Poughkeepsie Journal – Aug. 30
Moreover, Harrison, who is chair of the department of radiation oncology at H. Lee Moffitt Cancer Center and Research Institute, Tampa, Fla., said as leader of the organization's multidisciplinary team for the diagnosis and treatment of lung cancer, Connery's collaborative approach to patient care and cancer research flourished.

Chase your dreams! Take a chance! Oh, enough with the 'inspirational' posts
Tampa Bay Times – Aug. 29
Amanda Kinderman has had a challenging past six months. Romantic changes, life changes. The 29-year-old lab supervisor at Moffitt Cancer Center in Tampa leaned on online inspiration to help her.

Dendritic Cell Vaccines Offer Promising Signals as Glioblastoma Therapy
OncLive – Aug. 29
Currently, Moffitt Cancer Center is participating in a multicenter phase III randomized double- blind clinical trial examining the efficacy of a DC vaccine, DCVax-L, derived from autologous DCs pulsed with GBM lysates (NCT00045968).

Ipilimumab Side Effect Management in Melanoma
OncLive – Aug. 29
Jeffrey S. Weber, MD, PhD,Director, Donald A. Adam Comprehensive Melanoma Research Center, H. Lee Moffitt Cancer Center and Research Institute

Edwards Comprehensive Cancer Center
The State Journal (West Virginia) – Aug. 29
Certified by the American Board of Obstetrics and Gynecology, he also has completed extensive training in gynecologic cancer diagnosis and treatment and minimally invasive surgery, including daVinci surgery, at the University of South Florida and Moffitt Cancer Center.

HEALING NEUROPATHY & FIGHTING BRAIN CANCER
Senior Voice America – Aug. 29
Moffitt Cancer Center physician, Dr. Arnold Etame shares new hope for sufferers of Glioblastoma Multiforme, a deadly form of brain cancer.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.